Human iPS Cell–based Liver-like Tissue Engineering at Extrahepatic Sites in Mice as a New Cell Therapy for Hemophilia B

Instead of liver transplantation or liver-directed gene therapy, genetic liver diseases are expected to be treated effectively using liver tissue engineering technology. Hepatocyte-like cells (HLCs) generated from human-induced pluripotent stem (iPS) cells are an attractive unlimited cell source for...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Ryota, Takayama, Kazuo, Akita, Naoki, Nagamoto, Yasuhito, Hosokawa, Daiki, Iizuka, Shunsuke, Sakurai, Fuminori, Suemizu, Hiroshi, Ohashi, Kazuo, Mizuguchi, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898695/
https://www.ncbi.nlm.nih.gov/pubmed/29637813
http://dx.doi.org/10.1177/0963689717751734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898695/
https://www.ncbi.nlm.nih.gov/pubmed/29637813
http://dx.doi.org/10.1177/0963689717751734

Ejemplares similares